Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
WEB-Application: The patients of the Web-application arm will be trained on the devices and the application will be installed either on their smartphone or on another support (computer, tablet).
Standard accompaniment: Personalized schedule of medical follow-up given to the patient
Study summary
The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.
Eligibility
Primary outcome measure(s)
- Observance of hormontherapy — 18 months
Evaluate the benefit of a web-based application on hormone therapy compliance (Morisky questionnary; answer Yes or No; 8 questions)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre François baclesse | Caen | France |
More Centre Francois Baclesse trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04554927 on ClinicalTrials.gov ↗ ← All trials in France